鹿児島大学大学院 医歯学総合研究科 心臓血管・高血圧内科学

Facebook

Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University

研究について

臨床研究:業績

【2012】国際学会

  • 16th Asian-Pacific Congress on Doppler and Echocardiography
    (2012年3月, Fukuoka, Japan)
  • Takasaki K.
  • International Interesting Cases: Cases in which 3D transesophageal echocardiography was useful for evaluation of prosthetic valve dysfunction.
  • Yuasa T, Horizoe Y, Ueya N, Kono M, Kubota K, Mizukami N, Kuwahara E, Chaen H, Takasaki K, Kisanuki A, Hamasaki S, Tei C.
  • Assessment of pulmonary hypertension using cardiac time interval analysis.
  • 61th American College of Cardiology Annual Scientific Session 2012
    (2012年3月, Chicago, USA)
  • Ninomiya Y, Tsurugida M, Anzaki K, Kihara K, Hamasaki S, Tei C.
  • The effect of coronary flow reserve after reperfusion of acute myocardial infarction on left ventricular remodeling and function.
  • Angioplasty Summit TCTAP 2012
    (2012年4月, Souel, Korea)
  • Tsurugida M, Ninomiya Y, Kihara K, Hamasaki S.
  • Efficacy of simple stenting without kissing balloon dilatation for coronary bifurcation lesions: evaluation by myocardial ischemia using myocardial scintigraphy.
  • 2012 American Society of Hypertension Annual Scientific Meeting
    (2012年5月, New York, USA)
  • McKie PM, Ichiki T, Cataliotti A, Chen HH, and Burnett JC, Jr.
  • Subcutaneous delivery of M-ANP in conscious canines: an innovative designer natriuretic peptide for hypertension.
  • 15th Annual Scientific Meeting of Heart Failure Society of America (HFSA)
    (2012年9月, Seattle, USA)
  • Ichiki T, Huntley BK, Sandberg SM, and Burnett JC, Jr.
  • All three pre/prohormones are processed in normal human blood into biologically active mature peptides.
  • McKie PM, Cataliotti A, Ichiki T, Chen HH, Sangaralingham SJ, and Burnett JC, Jr.
  • Subcutaneous deliver of M-ANP in conscious canines: an innovative designer guanylyl cyclase activator for cardiovascular disease.
  • Sangaralingham SJ, Ritman EL, McKie PM, Ichiki T, Lerman A, Scott CG, and Burnett JC, Jr.
  • Cardiac micro-CT demonstrates alterations in the aging coronary vasculature in association with myocardial fibrosis.
  • Sangaralingham SJ, Heublein DM, Huntley BK, Ichiki T, Sandberg SM, and Burnett JC, Jr.
  • Circulating molecular forms of C-type natriuretic peptide in aging humans and their biological actions in cultured human cardiac fibroblasts: a potential therapeutic and diagnostic opportunity.
  • 8th Asian Interventional Cardiovascular Therapeutics Conference 2012
    (2012年10月, Delhi, India)
  • Liang M, Kajiya T, Tan HC, Low AF.
  • Initial experience in bioresorbable vascular scaffold using the ABSORB stent in patient with significant coronary artery disease.
  • Scientific Session of American Heart Association
    (2012年11月, Los Angels, USA)
  • Ikeda Y, Sadoshima J.
  • Cardiac specific disruption of Drp-1 causes the development of cardiac dysfunction via inhibition of autophagy and induction of apoptosis.
  • Ichiki T, Sandberg SM, Huntley BK, Heublein DM, Sangaralingham SJ, and Burnett JC, Jr.
  • The natriuretic peptide prohormones are processed into active peptides in the normal human circulation and the processing is preserved in heart failure.
  • Ichiki H, Oketani N, Iriki Y, Okui H, Maenosono R, Namino F, Ishida S, Ninomiya Y, Matsushita T, Hamasaki S, Tei C.
  • The comparison of warfarin and dabigatran in the incidence of asymptomatic cerebral micro thromboembolism after AF ablation.
  • Akasaki Y, Miyauchi T, Furusho Y, Ikeda Y, Ide K, Miyata M.
  • Thermal therapy prevented the transition from cardiac hypertrophy to heart failure.
  • Fujita T, Fujino N, Konno T, Asakura M, Kitakaze M, Kubo T, Doi Y, Kinugawa S, Tsutsui H, Komuro I, Anan R, Tei C, Yamagishi M.
  • Scientific sessions and resuscitation science symposium: Impact of sarcomere gene mutations on clinical outcome of left ventricular hypertrophy: evidence from comparison with hypertension-related hypertrophy.
  • Ueya N, Yuasa T, Horizoe Y, Chaen H, Kubota K, Kuwahara E, Takasaki K, Mizukami N, Kisanuki A, Hamasaki S.
  • Right ventricular diastolic filling time is an accurate parameter to estimate pulmonary pressure: comparison echocardiographic right ventricular diastolic function with invasive pulmonary hemodynamic variables.
  • Iriki Y, Oketani N, Okui H, Ichiki H, Ishida S, Ninomiya Y, Maenosono R, Namino F, Matsushita T, Miyata M, Hamasaki S.
  • Atrial fibrillation termination areas during substrate ablation guided by complex fractionated atrial electrograms are located commonly in the same anatomic regions of the atria with or without preceding pulmonary vein isolation.
  • Iriki Y, Oketani N, Okui H, Ichiki H, Ishida S, Ninomiya Y, Maenosono R, Namino F, Matsushita T, Miyata M, Hamasaki S.
  • The common locations of key areas to ablate for atrial fibrillation termination guided by complex fractionated atrial electrograms after pulmonary vein isolation: Paroxysmal vs. persistent atrial fibrillation.
  • Otsuji H, Kadota K, Goto T, Kato H, Yamamoto H, Oka N, Fuku Y, Tanaka H, Tada T, Habara S, Shigemoto Y, Hasegawa D, Otsuru S, Saito N, Hayakawa Y, Miyake K, Hyodo Y, Ozaki M, Kubo S, Ichinohe T, Mitsudo K.
  • Peri-stent contrast staining after Drug-eluting balloon angioplasty for treatment of coronary In-stent restenosis.
  • Arikawa R, Yamaguchi H, Takaoka J, Miyamura A, Atsuchi N, Ninomiya T, Chaen H, Yoshinaga J, Atsuchi Y.
  • Qualitative OCT assessment in late catch-up lesions after DES implantations.
  • McKie PM, Ichiki T, Cataliotti A, Huntley BK, Chen HH, and Burnett JC, Jr.
  • Subcutaneous delivery of M-ANP, a designer natriuretic peptide and guanylyl cyclase-A stimulator, potently activates cyclic GMP and reduces blood pressure in conscious canines.